P Fitscha
Overview
Explore the profile of P Fitscha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
129
Citations
148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Weiss K, Fitscha P, Virgolini I, OGrady J, Sinzinger H
Platelets
. 2010 Nov;
2(1):41-3.
PMID: 21043960
Calcium channel blockers are known to inhibit platelet aggregation in vitro and ex vivo. We studied the influence of a single oral dose of diltiazem (60 mg), nifedipine (10 mg)...
2.
Palumbo B, Oguogho A, Fitscha P, Sinzinger H
Vasa
. 2000 Oct;
29(3):179-85.
PMID: 11037715
Background: It has been postulated that adhesion molecules (AM) may be involved in development and progression of human atherosclerosis. We examined whether prostaglandin (PG) E1 affects circulating levels of the...
3.
Schweeger I, Fitscha P, Sinzinger H
Thromb Res
. 2000 Mar;
97(6):411-20.
PMID: 10704650
In this study we examined in 100 patients testing positive for Helicobacter pylori infection whether successful eradication therapy with pantoprazole, clarithromycin, and metronidazole alters fibrinogen and other acute phase response...
4.
Kritz H, Sinzinger H, Fitscha P, OGrady J
Prostaglandins Leukot Essent Fatty Acids
. 1999 Jan;
59(5):305-12.
PMID: 9888204
During the recent past it has been discussed that calcium antagonists may exert antiatherosclerotic actions at the vessel wall. Apolipoprotein B containing lipoproteins were isolated by immunoaffinity chromatography and radiolabeled...
5.
Kritz H, Oguogho A, Fitscha P, Kaliman J, Rogatti W, Sinzinger H
Thromb Res
. 1997 Jul;
87(2):257-61.
PMID: 9259117
No abstract available.
6.
Kritz H, Sinzinger H, Lupattelli G, Virgolini I, Fitscha P, OGrady J
Eur J Clin Pharmacol
. 1997 Jan;
52(3):191-7.
PMID: 9218925
Objective: An increased apo B-containing lipoprotein influx and cholesterol ester accumulation in arteries are well-known events in human atherogenesis. In vitro and experimental animal studies have provided evidence of a...
7.
Sinzinger H, Fitscha P, Kritz H
Agents Actions Suppl
. 1997 Jan;
48:92-106.
PMID: 9177101
A variety of in-vitro antiatherosclerotic actions, among them those on vascular smooth muscle cells (mitotic activity, proliferation, extracellular matrix production), have been identified especially for PGE1 and PGI2, and proven...
8.
Sinzinger H, Lupattelli G, Kritz H, Fitscha P, OGrady J
Prostaglandins
. 1996 Aug;
52(2):77-91.
PMID: 8880894
The in-vivo low-density lipoprotein (LDL)-uptake by the liver was monitored during the initial 60 minutes after injection of radiolabelled LDL. LDL-uptake by the liver as evidenced by the liver/blood pool...
9.
Sinzinger H, Fitscha P, Kritz H, Rogatti W, Grady J
Prostaglandins
. 1996 Jan;
51(1):61-8.
PMID: 8900444
Prostaglandin E1 (PGE1) has been claimed to have cytoprotective effects and also to decrease thrombogenicity. The effect of intraarterial (i.a.) and intravenous (i.v.) administration of PGE1 on the number of...
10.
Rodrigues M, Fitscha P, Sinzinger H
J Physiol Pharmacol
. 1994 Dec;
45(4):533-9.
PMID: 7727795
The PGI2/NO axis is well accepted for its central regulatory role in maintaining haemostatic balance in large arteries. Earlier findings suggest that PGD2 may also play a role in haemostatic...